Abciximab

BreastfeedingPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Anticoagulants, Antiplatelets, Collagenase, Dasatinib, Dextran, Drotrecogin Alfa, Fondaparinux, Glucosamine, Herbals with anticoagulant properties, Lepirudin, Monoclonal antibodies, NSAIDs, Omega-3 Fatty Acids, Pentosan, Pentoxifylline, Prostacyclin analogues, Reteplase, Salicylates, Thrombolytic agents, Tositumomab & Iodine131, Trastuzumab

PREGNANCY CATEGORY: C

Our database has 24 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top